ReviewInfection & chemotherapy2025
Korea's National Action Plan on Antimicrobial Resistance: Focusing on the Appropriate Use of Antibiotics.
Review in Infection & chemotherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Duration of protective effect after benzathine penicillin G prophylaxis for recurrent cellulitis: a 14-day window of efficacy.Infection · 2026Article
- Rapid microbiological diagnostics for sepsis in critical care: integrating technological advances with antimicrobial stewardship.Acute and critical care · 2026Article
- Development of indicators to evaluate the effectiveness of antimicrobial stewardship programs in Korea: a Delphi consensus study.Antimicrobial resistance and infection control · 2026Article
- Clinical impact of a multidisciplinary remote-based hybrid antibiotic stewardship program in critically ill patients during COVID-19 pandemic in Korea: a prospective pilot implementation study.Antimicrobial resistance and infection control · 2026Article
- Lessons From the Coronavirus Disease 2019 Pandemic: Implications for Antimicrobial Stewardship for COVID-19 Management.Journal of Korean medical science · 2026Review
- Pediatric Pneumococcal Eye Infection and Changes in Antibiotic Susceptibility: A Retrospective Study.Infection & chemotherapy · 2026Article
- Impact of pathophysiologically relevant underlying disease burden on pathogen distribution and antimicrobial resistance in patients with device-associated urinary tract infections.Frontiers in cellular and infection microbiology · 2026Article
- Changes in Antimicrobial Resistance in Pediatric Urinary Pathogens Before, During, and After the COVID-19 Pandemic.Antibiotics (Basel, Switzerland) · 2025Article
- Laying the groundwork for an inter-ministerial One Health response to antimicrobial resistance in South Korea.One health (Amsterdam, Netherlands) · 2025Review
- Implementation and Early Outcomes of an Antimicrobial Stewardship Program in South Korea.Antibiotics (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance (AMR) is recognized as one of the top ten global public health threats. Since the coronavirus disease 2019 pandemic, there has been a notable increase in global concern regarding AMR, leading to a strong call for a government-led response to address this issue. Since 2016, the Korean government has established and implemented a robust social foundation for managing AMR. This foundation encompasses several elements: enhancing the medical environment for infection prevention, providing support for the antimicrobial stewardship program in healthcare organizations, strengthening cooperation among multidisciplinary policy ministries, requiring veterinarians to prescribe antimicrobials in non-human fields, and enhancing food safety management in livestock and aquatic products. However, as the threat of AMR has intensified during the ongoing pandemic, the necessity for implementing a National Action Plan becomes even more critical. Therefore, the Third National Action Plan 2026-2030 is crucial to take into account several critical factors: raising awareness of AMR, strengthening of antimicrobial stewardship, halting the spread of antimicrobial-resistant bacteria, strengthening surveillance of antimicrobial use and AMR rates, strengthening internal and external collaborative efforts to combat AMR, and the final factor to consider is to enhance further antimicrobial development and diagnostic technologies to better manage and prevent AMR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.